Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/14/2018
Chinese Pharmacopoeia Commission Announces Proposed Addition of 40 Bio...
8/14/2018
Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery
8/14/2018
IQVIA: Peeking Into China's Healthcare Deals
8/14/2018
State Council Issues Notice to Divide Fiscal Responsibilities of Centr...
8/14/2018
SCMP: Fierce Competition in China's Nascent Immuno-therapy Cancer Drug...
8/14/2018
EU: Zhejiang Tianyu the Second Chinese Producer of Tainted Heart Drug
8/14/2018
China National Drug Administration Sets Guidelines for Overseas Drug T...
8/14/2018
Big Pharma Opportunities Aplenty in China
8/14/2018
Sihuan Pharma's Self-Developed Anticancer Pirotinib Commenced Phase II...
8/14/2018
India's Pharmexcil to sign MoU with China Trade Body for Expedite Drug...
8/13/2018
Haisco and Pneuma Enter Equity Investment and China Distribution Deal
8/13/2018
SMEI: Chinese Drug Terminal Market Up 6.9% in H1
8/12/2018
Sanpower Sell Dendreon to Affiliate Nanjing Cenbest for $820M
8/10/2018
Recent Executive Moves
8/9/2018
Cross-Border Funding in the Life Sciences
8/9/2018
Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
8/9/2018
CDE Publicizes Batch 31 of Drug Applications To Be Granted Priority Re...
8/9/2018
SMIA Official: BMI Negotiation for 18 Anticancers To Be Concluded by S...
8/9/2018
China Approves Amgen's Anti-cholesterol Drug Repatha
8/9/2018
Pfizer's Breast Cancer Drug Ibrance Receives Approval in China
8/9/2018
BeiGene Drops 5% on Hong Kong IPO Debut
8/9/2018
EdiGene Raises $15M Pre-Series B Led by Lilly Asia Ventures
8/9/2018
Harbour BioMed and Glenmark Pharma Sign Agreement for Greater China to...
8/8/2018
CDE Solicits Comments on List of Urgently-needed New Drugs Marketed Ov...
8/8/2018
CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 Trial for Hepat...
8/8/2018
IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
8/8/2018
Novartis Voluntarily Withdraws Zemeta for Injection in China, Followin...
8/8/2018
Novartis China Reorganizes to Better Position for New Business
8/7/2018
CNDA Approves Gilead's HIV Drug Genvoya
8/7/2018
MorphoSys and I-Mab Announce China IND Submission of mAb for MM
Page:
313
/
774
Total number of articles:
23207
:
[First]
[<<]
[311]
[312]
[313]
[314]
[315]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit